CH602707A5 - - Google Patents

Info

Publication number
CH602707A5
CH602707A5 CH224374A CH224374A CH602707A5 CH 602707 A5 CH602707 A5 CH 602707A5 CH 224374 A CH224374 A CH 224374A CH 224374 A CH224374 A CH 224374A CH 602707 A5 CH602707 A5 CH 602707A5
Authority
CH
Switzerland
Application number
CH224374A
Inventor
Heulwen Moira Ridgway
David Martin Waters
Mervyn Evan Peel
Gwynn Pennant Ellis
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of CH602707A5 publication Critical patent/CH602707A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
CH224374A 1973-02-26 1974-02-18 CH602707A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB924973A GB1433774A (en) 1973-02-26 1973-02-26 Heterocyclic compounds apparatus for conveying articles

Publications (1)

Publication Number Publication Date
CH602707A5 true CH602707A5 (en) 1978-07-31

Family

ID=9868317

Family Applications (1)

Application Number Title Priority Date Filing Date
CH224374A CH602707A5 (en) 1973-02-26 1974-02-18

Country Status (14)

Country Link
JP (1) JPS5029574A (en)
AT (1) AT329562B (en)
AU (1) AU474797B2 (en)
BE (1) BE811246A (en)
CA (1) CA1025856A (en)
CH (1) CH602707A5 (en)
DE (1) DE2407744A1 (en)
FR (1) FR2218896B1 (en)
GB (1) GB1433774A (en)
IE (1) IE38886B1 (en)
LU (1) LU69479A1 (en)
NL (1) NL7402613A (en)
SE (1) SE7401984L (en)
ZA (1) ZA74883B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2324304A2 (en) * 1975-09-22 1977-04-15 Roussel Uclaf Analgesic (4)-hydroxy-quinoline-(3)-amides - prepd. from a quinoline-(3)-carboxyl chloride and an amine
US4186201A (en) 1977-02-07 1980-01-29 Riker Laboratories, Inc. Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds
US4390541A (en) 1980-12-19 1983-06-28 Lilly Industries Limited Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease
FR2509728A1 (en) * 1981-07-17 1983-01-21 Roussel Uclaf NOVEL QUINOLINE DERIVATIVES, THEIR SALTS, PREPARATION METHOD, MEDICAMENT APPLICATION AND COMPOSITIONS COMPRISING THE SAME
US4377579A (en) 1981-12-03 1983-03-22 Minnesota Mining And Manufacturing Company N-(Tetrazol-5-yl)phenazine-1-carboxamides
FR2537140B1 (en) * 1982-12-07 1986-07-18 Roussel Uclaf NOVEL 4-HYDROXY-3-QUINOLEINE CARBOXAMIDE DERIVATIVES, SALTS THEREOF, PROCESS FOR THEIR PREPARATION, APPLICATION AS MEDICAMENTS, AND COMPOSITIONS CONTAINING THEM
ATE82282T1 (en) * 1987-01-20 1992-11-15 Dainippon Pharmaceutical Co AROMATIC HETEROCYCLIC CARBONIC ACID REAMIDES, PROCESSES FOR THE PREPARATION AND MEDICATIONS CONTAINING THEM.
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
US6143760A (en) 1997-08-25 2000-11-07 Neurogen Corporation Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
JP2001514181A (en) * 1997-08-25 2001-09-11 ニューロゲン コーポレイション Substituted 4-oxo-naphthyridine-3-carboxamides as GABA brain receptor ligands
EP1056724B1 (en) 1998-02-26 2005-05-25 Neurogen Corporation Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
DK1503759T3 (en) * 2002-05-14 2009-04-14 Univ California Substituted quinolone carboxylic acids, their derivatives, site of action and uses thereof
EP1650192A4 (en) 2003-07-24 2007-03-21 Astellas Pharma Inc Quinolone derivative or salt thereof
RU2556984C2 (en) * 2004-06-24 2015-07-20 Вертекс Фармасьютикалз Инкорпорейтед Modulators of atp-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
EP2502913A3 (en) * 2004-06-24 2013-11-27 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
ME02970B (en) 2004-06-24 2018-07-20 Vertex Pharma Modulators of ATP-binding cassette transporters
LT1993360T (en) 2005-12-28 2017-06-12 Vertex Pharmaceuticals Incorporated Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
EP2821400B1 (en) 2009-03-20 2017-09-27 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
WO2013130669A1 (en) 2012-02-27 2013-09-06 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administration thereof
US9403802B2 (en) 2012-03-02 2016-08-02 Takeda Pharmaceutical Company Limited Heterocyclic compound and use therefor
WO2014077401A1 (en) 2012-11-19 2014-05-22 武田薬品工業株式会社 Nitrogen-containing heterocyclic compound
AU2015330923B2 (en) 2014-10-07 2020-03-12 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
CN105330602B (en) * 2015-12-07 2018-02-09 江南大学 A kind of deccox analog and its application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1383088A (en) * 1972-07-03 1975-02-05 Allen & Hanburys Ltd Pharmacologically active quinaldamide derivatives

Also Published As

Publication number Publication date
ATA149974A (en) 1975-08-15
ZA74883B (en) 1974-12-24
JPS5029574A (en) 1975-03-25
NL7402613A (en) 1974-08-28
FR2218896B1 (en) 1977-09-09
AU6559274A (en) 1975-08-14
AT329562B (en) 1976-05-25
CA1025856A (en) 1978-02-07
FR2218896A1 (en) 1974-09-20
DE2407744A1 (en) 1974-08-29
SE7401984L (en) 1974-08-27
IE38886L (en) 1974-08-26
BE811246A (en) 1974-08-19
LU69479A1 (en) 1975-05-21
GB1433774A (en) 1976-04-28
AU474797B2 (en) 1976-08-05
IE38886B1 (en) 1978-06-21

Similar Documents

Publication Publication Date Title
AR201758A1 (en)
AR201235Q (en)
AR201231Q (en)
FR2218896B1 (en)
AU450229B2 (en)
AR201229Q (en)
AU447540B2 (en)
AR193950A1 (en)
AR200885A1 (en)
AR201432A1 (en)
AR210729A1 (en)
AU1891376A (en)
CH559030A5 (en)
BG20243A1 (en)
CH559143A5 (en)
CH560351A5 (en)
CH560357A5 (en)
CH560402A5 (en)
CH561394A5 (en)
AU479404A (en)
CH1753673A4 (en)
CH1676173A4 (en)
CH1622873A4 (en)
CH1195773A4 (en)
BG25988A3 (en)

Legal Events

Date Code Title Description
PL Patent ceased